Trials / Completed
CompletedNCT01422265
Patient Reported Symptoms in Ovarian Cancer (PRECISION)
Patient Reported Symptoms in Ovarian Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter, observational, prospective study will include approximately 20 US-based centers, and approximately 142 patients diagnosed with epithelial ovarian cancer, primary peritoneal carcinoma or fallopian tube carcinoma, whose disease has recurred \> 6 months after first-line platinum-based chemotherapy (first recurrence). Patients who have completed second-line chemotherapy and are currently in observation or undergoing bevacizumab maintenance treatment will be eligible to participate in the study.
Conditions
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2011-08-23
- Last updated
- 2016-11-02
Locations
31 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01422265. Inclusion in this directory is not an endorsement.